Skip to main content
OpenTrials
Completed

NCT Number: NCT00202709

Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?

The purpose of this study is to find out if Thought Field Therapy has effect on certain anxiety disorders; agoraphobia, social phobia, and post traumatic stress disorder (PTSD).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Agoraphobia Anxiety Disorders Mental Disorders PTSD Phobia, Social Phobic Disorders Social Phobia Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sorlandet Hospital

Arendal, 4809, Norway

About this study

Thought Field Therapy is an alternative treatment method that has been shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 52 patients, with one or more of the diagnoses agoraphobia, social phobia and/or PTSD, where randomized to either treatment with TFT or a wait list. The treatment group all got treatment in one week. 2 1/2 months later both the treatment group and the control group were tested on the same items as before the treatment started. After this evaluation phase the control group got the same treatment as the treatment or study group. Both groups were evaluated 3 and 12 months after treatment, the study group also 6 months after treatment. 4 patients were omitted because they changed groups. The study were performed from May 2002 until June 2003.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • One or more of the study diagnoses agoraphobia, social phobia and/or PTSD

Exclusion criteria

  • Ongoing psychosis
  • Ongoing serious drug problems

Treatment and study plan

Thought Field Therapy (TFT)

Behavioral

Treatment with TFT twice in one week

Other names: Wait list control

Primary outcomes

  1. Global symptom index (gsi) on the Symptom checklist 90 revised (SCL-90-R)

    Time frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

Secondary outcomes

  1. Davidson Trauma Scale

    Time frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  2. Liebowitz Social Anxiety Scale

    Time frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  3. Hospital Anxiety and Depression Scale (HADS)

    Time frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  4. Fear Questionnaire (FQ)

    Time frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  5. Sheehan Disability Scale

    Time frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

Sponsors and collaborators

Lead sponsor

Sorlandet Hospital HF

Other Gov

Registry information

Official study title

Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder, a Prospective, Randomized Pilot Study With Wait List as Control Group.

Important dates

Study start
2002
Primary completion
2003
Study completion
2003
First posted
Sep 20, 2005
Registry last updated
Jul 28, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.